©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Mar 5, 2025; 16(1): 97918
Published online Mar 5, 2025. doi: 10.4292/wjgpt.v16.i1.97918
Published online Mar 5, 2025. doi: 10.4292/wjgpt.v16.i1.97918
Table 3 Diseases with symptoms overlapping with gastroesophageal reflux disease
| Ref. | Diseases with overlapping symptoms |
| [115] | Eosinophilic esophagitis |
| [116] | Infectious esophagitis |
| Esophageal candidiasis | |
| Herpes and cytomegalovirus esophagitis | |
| [117] | Drug-induced esophagitis |
| [118] | Achalasia and esophageal motility disorders |
| [119] | Pharyngeal and esophageal diverticula, rings, and webs |
| [120] | Disorders of gastric motility/ gastroparesis |
| [121] | Gastritis & peptic ulcer disease |
| [122] | Gluten-related disorders |
| [123] | Functional gastrointestinal disorders: Functional chest pain, functional heartburn, reflux hypersensitivity, globus sensation, functional dysphagia, functional dyspepsia, postprandial distress syndrome, epigastric pain syndrome, belching disorders, and rumination syndrome |
| [124] | Functional abdominal bloating/distension and esophageal and gastric carcinoma |
| [125] | Cardiac disease |
| [126] | Gall bladder and pancreatic diseases |
- Citation: Wickramasinghe N, Devanarayana NM. Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impact. World J Gastrointest Pharmacol Ther 2025; 16(1): 97918
- URL: https://www.wjgnet.com/2150-5349/full/v16/i1/97918.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i1.97918